{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T23:46:37Z","timestamp":1794008797063,"version":"4.8.0"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001505","name":"Health Research Council of New Zealand","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001505","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001516","name":"National Heart Foundation of New Zealand","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001516","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.clinbiochem.2020.02.001","type":"journal-article","created":{"date-parts":[[2020,2,7]],"date-time":"2020-02-07T05:03:24Z","timestamp":1581051804000},"page":"41-47","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Analytical and biological assessment of circulating human erythroferrone"],"prefix":"10.1016","volume":"79","author":[{"given":"Sarah","family":"Appleby","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janice","family":"Chew-Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard W.","family":"Troughton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Mark","family":"Richards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Pemberton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.clinbiochem.2020.02.001_b0005","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1182\/blood.V84.6.1697.1697","article-title":"Regulators of iron balance in humans","volume":"84","author":"Finch","year":"1994","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.clinbiochem.2020.02.001_b0010","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/ng.2996","article-title":"Identification of erythroferrone as an erythroid regulator of iron metabolism","volume":"46","author":"Kautz","year":"2014","journal-title":"Nat. Genet."},{"issue":"21","key":"10.1016\/j.clinbiochem.2020.02.001_b0015","article-title":"The erythroid factor erythroferrone and its role in iron homeostasis","volume":"122","author":"Jung","year":"2013","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.clinbiochem.2020.02.001_b0020","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/MOH.0000000000000132","article-title":"New insights into iron regulation and erythropoiesis","volume":"22","author":"Kim","year":"2015","journal-title":"Curr. Opin. Hematol."},{"issue":"21","key":"10.1016\/j.clinbiochem.2020.02.001_b0025","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V124.21.213.213","article-title":"Role of erythroferrone in the pathophysiology of common anemias","volume":"124","author":"Kautz","year":"2014","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.clinbiochem.2020.02.001_b0030","doi-asserted-by":"crossref","DOI":"10.1097\/HS9.0000000000000035","article-title":"Erythroferrone: an erythroid regulator of hepcidin and iron metabolism","volume":"2","author":"Coffey","year":"2018","journal-title":"HemaSphere"},{"issue":"16","key":"10.1016\/j.clinbiochem.2020.02.001_b0035","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1182\/blood-2014-06-584607","article-title":"Erythroferrone contributes to recovery from anemia of inflammation","volume":"124","author":"Kautz","year":"2014","journal-title":"Blood"},{"issue":"17","key":"10.1016\/j.clinbiochem.2020.02.001_b0040","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1182\/blood-2015-07-658419","article-title":"Erythroferrone contributes to hepcidin suppression and iron overload in a mouse model of beta-thalassemia","volume":"126","author":"Kautz","year":"2015","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.clinbiochem.2020.02.001_b0045","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1182\/blood-2017-04-777987","article-title":"Immunoassay for human serum erythroferrone","volume":"130","author":"Ganz","year":"2017","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.clinbiochem.2020.02.001_b0050","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1161\/CIRCULATIONAHA.109.909937","article-title":"B-type natriuretic peptide signal peptide circulates in human blood: evaluation as a potential biomarker of cardiac ischemia","volume":"122","author":"Siriwardena","year":"2010","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.clinbiochem.2020.02.001_b0055","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1093\/eurjhf\/hfp099","article-title":"Regional clearance of amino-terminal pro-brain natriuretic peptide from human plasma","volume":"11","author":"Palmer","year":"2009","journal-title":"Eur. J. Heart Fail."},{"issue":"4","key":"10.1016\/j.clinbiochem.2020.02.001_b0060","doi-asserted-by":"crossref","first-page":"e141","DOI":"10.3324\/haematol.2017.181743","article-title":"Levels of the erythropoietin-responsive hormone erythroferrone in mice and humans with chronic kidney disease","volume":"103","author":"Hanudel","year":"2018","journal-title":"Haematologica"},{"key":"10.1016\/j.clinbiochem.2020.02.001_b0065","article-title":"The hepcidin-25\/erythroferrone ratio predicts improvement of anemia in hemodialysis patients treated with ferric citrate hydrate","author":"Hara","year":"2018","journal-title":"Nephrology (Carlton, Vic.)"},{"issue":"3","key":"10.1016\/j.clinbiochem.2020.02.001_b0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151601","article-title":"Associations among erythroferrone and biomarkers of erythropoiesis and iron metabolism, and treatment with long-term erythropoiesis-stimulating agents in patients on hemodialysis","volume":"11","author":"Honda","year":"2016","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.clinbiochem.2020.02.001_b0075","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/ejh.13021","article-title":"Erythroferrone and iron status parameters levels in pediatric patients with iron deficiency anemia","volume":"100","author":"El Gendy","year":"2018","journal-title":"Eur. J. Haematol."},{"issue":"12","key":"10.1016\/j.clinbiochem.2020.02.001_b0080","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1161\/CIRCRESAHA.118.313777","article-title":"Myonectin is an exercise-induced myokine that protects the heart from ischemia-reperfusion injury","volume":"123","author":"Otaka","year":"2018","journal-title":"Circ. Res."}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912019312445?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912019312445?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:55:18Z","timestamp":1757865318000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912019312445"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":16,"alternative-id":["S0009912019312445"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2020.02.001","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analytical and biological assessment of circulating human erythroferrone","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2020.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}